At the Intersection of Science and Law
autor: DLA Piper
Revolutionizing Clinical Trials: A discussion on diversity and…
O tym podcaście
In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.
Odcinki
- Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches · 30 min · Odcinek 14In this episode, Quest Diagnostics’ Adam Donat is joined by DLA Piper’s Kirsten Axelsen, Rachel Portman, and Jae Kim to discuss the increasing complexity and cost of clinical…
- Life sciences companies and the risks posed by the mifepristone litigation · 33 min · Sezon 1 Odcinek 13In this episode, a cross-disciplinary team of FDA regulatory lawyers and life sciences litigators discuss the implications of the mifepristone litigation for life sciences…
- Trade secrets protection in the life sciences sector · 21 min · Sezon 1 Odcinek 12DLA Piper’s Roberto Valenti and Ray Miller discuss trade secrets protection in the US and Europe and the peculiarities within the life sciences sector. Our speakers provide…
- Cross-border considerations for privacy in clinical trials · 18 min · Sezon 1 Odcinek 11Published in Chambers Expert Focus. With the recent publication of our Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans…
- Global Life Sciences Supply Chain Insights · 28 min · Sezon 1 Odcinek 10Published in Chambers Expert Focus. Lauren Murdza and Richard Taylor share their insights on supply chain issues in the life sciences sector in the latest episode of At the…
- AI risk assessments: Future-proofing your innovation when rules can change mid-game · 25 min · Sezon 1 Odcinek 9Published in Chambers Expert Focus. DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and…
- The rise of global telehealth · 26 min · Sezon 1 Odcinek 8DLA Piper partners Kristi Kung and Greg Bodulovic discuss the rise of telehealth amid the COVID-19 pandemic, as well as advancements in technology aiming to address disparate…
- Advising the advisor: Tips for navigating the life sciences and regulatory environment · 31 min · Sezon 1 Odcinek 7DLA Piper managing partner Emilio Ragosa is joined by Kevin Sheridan, Joint Global Head of Healthcare Investment Banking at Jefferies LLC, to discuss the importance of advisors…
- The moral imperative: Balancing innovation, regulation and prescription drug availability · 31 min · Sezon 1 Odcinek 6DLA Piper's Jim Greenwood and Geoff Levitt are joined by Peter Kolchinsky, founding Partner and Portfolio Manager at RA Capital, to discuss the importance of – and complications…
- Incentivizing diverse representation in clinical trials · 23 min · Sezon 1 Odcinek 5Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by…
- The crossroad of science and law · 26 min · Sezon 1 Odcinek 4In this episode, DLA Piper’s Lucas Przymusinski and Raymond Williams are joined by Michael King, Vice President and Associate General Counsel at Jazz Pharmaceuticals, to discuss…
- Social media’s impact on the life sciences industry · 35 min · Sezon 1 Odcinek 3In this episode, DLA Piper’s Chris Campbell and Jody Rhodes are joined by Sarah Heineman, Senior Assistant General Counsel at Bayer, to discuss how social media affects the…
- Understanding AI and its use in drug discovery · 32 min · Sezon 1 Odcinek 2DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and…
- mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando · 26 minFor decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice President, Worldwide of Clinical…








